Archives for 2012

Developing Safer Chemo Treatments

Waning white blood-cell counts in chemotherapy patients are commonly taken as a warning of an increased risk of infection. Now, a new Israeli study suggests that it is critical to evaluate not only the quantity of these “neutrophil” blood cells essential to immunity against infection, but also their quality, which varies from one patient to another. Spread the Word • Email … [Read more...]

Israeli Device Uses EM Energy To Heal

The same Israeli inventor who brought the world pre-paid phone cards and voice over Internet protocol (VOIP) also had an idea for a portable medical device that could confer the healing properties of low electromagnetic frequencies. Nearly a decade after its conception, MDwave is now inching closer to the marketplace. Based on technology developed by Israel Defense Prize … [Read more...]

Israeli Scientists Battle Breast Cancer

One out of every eight women will develop breast cancer in her lifetime. It is the most commonly diagnosed non-skin cancer in women worldwide, and also strikes thousands of men. Though the three areas with the highest breast cancer rates are Western Europe, Australia/New Zealand and Northern Europe, Israel has taken a leading role in researching causes and treatments. The … [Read more...]

Computer Now Helps To Relieve Children’s Anxiety

A computer-based therapy relieves anxiety disorders in young patients without the need for drugs, according to an Israeli university study. An initial clinical trial in Israel showed that a computer-based technique called attention bias modification (ABM) can relieve anxiety in children without the use of drugs. The relatively new treatment was developed at the lab of … [Read more...]

This Drug Acts Like A Guided Missile On Cancer

A new drug delivery system puts thousands of toxic pharmaceutical molecules inside a targeted missile which goes off only when it reaches cancerous tissue. “Monoclonal antibodies” may sound like a great name for a heavy-metal band, but actually they’re the basis of best-selling pharmaceuticals raking in about $50 billion dollars a year. The two-year-old Israeli company … [Read more...]